Shannon John Patrick Jr

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Shannon John Patrick Jr's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-06 2026-01-05
PlS Planned sale
75,296 +29.5%
114.32
US$2,041,333 		75,296 +29.5% 114.32 US$2,041,333
2025-11-17 2025-11-13
PlS Planned sale
77,567 +34.0%
115.72
US$4,978,630 		77,567 +34.0% 115.72 US$4,978,630
2025-11-13 2025-11-13
PrS Proposed sale
49,214
327.63
US$886,841 		49,214 327.63 US$886,841
2023-11-17 2023-11-17
B Purchase
30,769 +2.2%
1.64
US$50,400 		30,769 +2.2% 1.64 US$50,400
2021-11-12 2021-11-12
B Purchase
60,000 +19.7%
2.10
US$126,000 		60,000 +19.7% 2.10 US$126,000
2021-11-12 2021-11-11
B Purchase
40,000 +15.2%
2.09
US$83,500 		40,000 +15.2% 2.09 US$83,500
2020-05-14 2020-05-13
B Purchase
22,000 +23.0%
3.55
US$77,994 		22,000 +23.0% 3.55 US$77,994
2020-05-11 2020-05-08
B Purchase
7,886 +9.0%
3.20
US$25,219 		7,886 +9.0% 3.20 US$25,219
2020-02-18 2020-02-14
B Purchase
12,048 +114.1%
4.15
US$49,999 		12,048 +114.1% 4.15 US$49,999